Alvotech ALVO 深 沪
等待开盘 06-30 09:30:00 美东时间
3.72
+0.040
+1.09%
华盛通- 最 高3.73
- 今 开3.61
- 成交量 69.04万股
- 最 低 3.61
- 昨 收 3.68
- 总市值 11.61亿
- 52周最高 9.94
- 市盈率 静 38.83
- 换手率 0.22%
- 52周最低 2.94
- 委 比 -75.20%
- 总股本 3.12亿
- 历史最高 18.00
- 量 比 0.74
- 振 幅 3.26%
- 历史最低 2.94
- 每 手 1
- 风险率 2.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Transactions of Managers and Closely Associated Persons
Celtic Lux Holdings S.a. r.l. (formerly Alvogen Lux Holdings S.a. r.l.) has acquired 10,133,333 shares in Alvotech at USD 3.75 per share on June 16, 2026, as notified to the Luxembourg CSSF.
06-22 22:48
Teva submits NDA for ecopipam for pediatric Tourette's
Teva Pharmaceutical Industries (TEVA) has submitted an NDA to the US FDA seeking approval of ecopipam for pediatric Tourette syndrome. The application is supported by phase 3 data that found ecopipam ...
06-19 05:20
Dave and Buster's Reports Downbeat Q1 Earnings, Joins Alvotech And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 0.1% on Tuesday. Shares of Dave and Buster’s Entertainment, Inc (NASDAQ:PLAY) fell sharply in pre-market trading as the company reported downbeat earnings for the first quarter. The company posted quarterly earnings of ...
06-16 20:05
Alvotech prices $85M stock offering, plans additional raise via private placement
Alvotech (ALVO) priced its previously announced underwritten public offering of 22.67M ordinary shares at $3.75 per share, expecting to raise about $85M in gross proceeds. The global biosimilars devel...
06-16 13:42
Alvotech Commences ~$125M Offering Of Ordinary Shares
Alvotech (NASDAQ:ALVO, ALVO-SDB))) ("Alvotech" or the "Company"), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has commenced an underwritten public offering of its ordinary shares (the "Offering...
06-16 04:16
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares
<p>Alvotech, a global biotechnology company specializing in biosimilar medicines, has launched an underwritten public offering of its ordinary shares, with an option for underwriters to purchase up to an additional 15%. Concurrently, the company expects to conduct a private placement of ordinary shares to certain European investors. The combined offering is anticipated to raise approximately $125 million, with proceeds allocated to biosimilar dev...
06-15 20:01
Alvotech 有望在年底前推出 5 款美国生物仿制药，临近转折点
阿尔沃泰克（纳斯达克股票代码：ALVO）创始人兼执行董事长罗伯特·韦斯曼在杰富瑞全球医疗保健会议上表示，公司正处“转折点”，预计年底前美国将有5款生物类似药上市...
06-15 15:21
Johnson & Johnson to buy Firefly Bio for $1B in cash
Johnson & Johnson (JNJ) has entered into a definitive agreement to acquire Firefly Bio, a biotechnology company advancing its proprietary Firelink degrader antibody conjugate platform, for $1B in cash...
06-08 20:42
Biggest stock movers Monday: NRIX, HON, and more
Stock futures edged lower Monday morning while crude oil prices marched higher as Wall Street faced a dual threat from escalating geopolitical conflict and mounting tech skepticism. Here are some of M...
06-08 18:09
Alvotech gains on FDA acceptance of Entyvio biosimilar BLA
Alvotech (ALVO) shares rose in premarket trading on Monday after the company said the U.S. Food and Drug Administration accepted for review its Biologics License Application for AVT16, a proposed inte...
06-08 16:29
